Disease Treatments

ASGCT on SciShow

ASGCT partnered with SciShow to discuss three groundbreaking gene therapy frontiers. These videos are a great complement to ASGCT's Patient Education portal and we're proud to support free educational community resources. Watch all three episodes on YouTube!

Watch Now

Parkinson's Disease

Parkinson’s degenerative neurological diseaseis a genetic disease that affects 1 in 100 people over the age of 60 and, over time, causes the death of brain cells, called neurons. However, gene therapy might offer hope for managing symptoms, or even improving the effects of existing medications.

Learn More

Spinal Muscular Atrophy

Gene therapy to treat SMA is now approved for clinical use in the United States.

Learn More

X-Linked Myotubular Myopathy

The full story on the first gene therapy clinical trials for X-Linked MTM.

Learn More

Leukodystrophy

Gene therapy for ALD, MLD and other leukodystrophy diagnoses are in the early stages, but preclinical studies have been promising.

Learn More

Blood Disorders

Gene therapies for sickle cell disease, beta-thalessemia, and Fanconi anemia all show promise and are at various stages of clinical trials.

Learn More

Inherited Retinal Diseases

Among the most developed gene therapies, Learn more about available treatments and others on the horizon for LCA, retinitis pegmentosa, choroideremia and more.

Learn More

More Resources

Additional websites, information, definitions and FAQs for patients, families, advocates, and the public.

Learn More
2022

ASGCT Policy Summit

September 26-27, 2022

Learn More

© 2000-2022 All rights reserved. American Society of Gene & Cell Therapy. 

Kentico CMS Development by Reason One | Powered by Kentico

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.